Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 75/100

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

Key Takeaway: Artivion, Inc. announced that it will release its first quarter 2026 financial results on May 7, 2026, after market close. A teleconference will follow at 4:30 p.m. ET, hosted by CEO Pat Mackin. Investors can access the live webcast and a replay on the company's website, along with the earnings press release.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is set to release its financial results, indicating ongoing operations.
  • The teleconference will provide insights into the company's performance.
  • The company continues to engage with investors through live webcasts.

Full Press Release Details

ATLANTA,April 23, 2026/PRNewswire/ --Artivion, Inc. (NYSE:AORT),a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2026 financial results will be released on Thursday, May 7, 2026, after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin, Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 4:30 p.m. ET. The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13759187.
The live webcast and replay can be accessed on the Investors section of the Artivion website atwww.artivion.comand by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website,www.artivion.com.

Contacts:

Artivion Gilmartin Group LLC
Lance A. Berry Brian Johnston
Executive Vice President, Chief Operating Officer & Chief Financial Officer Phone: 332-895-3222
Phone: 770-419-3355 [email protected]

Artivion

Gilmartin Group LLC

Lance A. Berry
Brian Johnston
Executive Vice President, Chief Operating Officer & Chief Financial Officer
Phone: 332-895-3222
Phone: 770-419-3355
[email protected]
SOURCE Artivion, Inc.

21%

Frequently Asked Questions

When will Artivion release its Q1 2026 financial results?

Artivion will release its Q1 2026 financial results on May 7, 2026.

What time is the teleconference for Artivion's financial results?

The teleconference will be held at 4:30 p.m. ET on May 7, 2026.

How can I access the teleconference replay?

The teleconference replay can be accessed by calling 877-660-6853 or 201-612-7415.

Who will host the teleconference for Artivion?

The teleconference will be hosted by Pat Mackin, CEO of Artivion.

Last updated: Apr 23, 2026